<table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.15550.009</object-id><label>Table 1.</label><caption><p>Prioritized ER proteostasis regulators.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15550.009">http://dx.doi.org/10.7554/eLife.15550.009</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th>Name</th><th>Structure</th><th>MW</th><th>Polar Surface Area</th><th>AlogP</th><th>Structural moieties <break/>(<xref ref-type="fig" rid="fig1s1">Figure 1&#8212;figure supplement 1B&#8211;C</xref>)</th><th>% ERSE-FLuc activation*</th><th>% XBP1-RLuc activation*</th><th>Promiscuity**</th></tr></thead><tbody><tr><td valign="middle"><p><bold>5</bold></p> </td><td valign="top"><inline-graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-15550-inf1-v1"/></td><td valign="middle"><p>271.2</p></td><td valign="middle"><p>41.13</p></td><td valign="middle">2.62</td><td valign="middle">-</td><td valign="middle">60.9 &#177; 6.0</td><td valign="middle">9.1 &#177; 0.7</td><td valign="middle">1 out of 31</td></tr><tr><td valign="middle"><bold>132</bold></td><td valign="top"><inline-graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-15550-inf2-v1"/></td><td valign="middle">283.3</td><td valign="middle">58.56</td><td valign="middle">3.27</td><td valign="middle">F</td><td valign="middle">140.1 &#177; 17.4</td><td valign="middle">10.3 &#177; 7.9</td><td valign="middle">2 out of 32</td></tr><tr><td valign="middle"><bold>145</bold></td><td valign="top"><inline-graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-15550-inf3-v1"/></td><td valign="middle">260.3</td><td valign="middle">75.36</td><td valign="middle">3.01</td><td valign="middle">F, H</td><td valign="middle">83.4 &#177; 6.3</td><td valign="middle">24.5 &#177; 4.7</td><td valign="middle">1 out of 31</td></tr><tr><td valign="middle"><bold>147</bold></td><td valign="top"><inline-graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-15550-inf4-v1"/></td><td valign="middle">255.3</td><td valign="middle">49.33</td><td valign="middle">3.35</td><td valign="middle">B, F</td><td valign="middle">63.2 &#177; 0.6</td><td valign="middle">17.5 &#177; 1.9</td><td valign="middle">1 out of 32</td></tr><tr><td valign="middle"><bold>148</bold></td><td valign="top"><inline-graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-15550-inf5-v1"/></td><td valign="middle">322.3</td><td valign="middle">149.12</td><td valign="middle">2.00</td><td valign="middle">B, F</td><td valign="middle">52.5 &#177; 14.3</td><td valign="middle">16.6 &#177; 2.4</td><td valign="middle">3 out of 31</td></tr><tr><td valign="middle"><bold>238</bold></td><td valign="top"><inline-graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-15550-inf6-v1"/></td><td valign="middle">314.7</td><td valign="middle">69.64</td><td valign="middle">2.94</td><td valign="middle">B, L</td><td valign="middle">68.2 &#177; 5.7</td><td valign="middle">61.1 &#177; 0.1.5</td><td valign="middle">2 out of 31</td></tr><tr><td valign="middle"><bold>258</bold></td><td valign="top"><inline-graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-15550-inf7-v1"/></td><td valign="middle">393.2</td><td valign="middle">91.15</td><td valign="middle">3.76</td><td valign="middle">C, D</td><td valign="middle">28.6 &#177; 6.1</td><td valign="middle">32.6 &#177; 1.0</td><td valign="middle">1 out of 31</td></tr><tr><td valign="middle"><bold>263</bold></td><td valign="top"><inline-graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-15550-inf8-v1"/></td><td valign="middle">257.2</td><td valign="middle">90.44</td><td valign="middle">3.10</td><td valign="middle">C</td><td valign="middle">20.7 &#177; 2.3</td><td valign="middle">2.4 &#177; 1.0</td><td valign="middle">1 out of 31</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p>*% Tg activation from triplicate confirmation screen at 6.8 &#956;M</p></fn><fn id="tblfn2"><p>** Number of screening assays in which the compound was found active</p></fn></table-wrap-foot></table-wrap>